SCHEMBL4354285

SCHEMBL4354285

O=C1N=C(N2CCSCC2)S/C1=C/c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
RAB9A P51151 2/20 0.58
NPC1 O15118 2/20 0.58
MAPT P10636 4/20 0.54
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ALOX5 P09917 2/20 0.53
PIM1 P11309 1/20 0.52
PIM2 Q9P1W9 1/20 0.52
HTT P42858 1/20 0.51
IDE P14735 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2B Q13224 1/20 0.50
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
DCTPP1 Q9H773 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354286 1.00 MEN1 (0.58) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4360822 0.88 ALDH1A1 (0.64) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4360819 0.88 ALDH1A1 (0.64) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4351235 0.85 MAPT (0.63) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4351239 0.85 MAPT (0.63) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4350565 0.83 ALDH1A1 (0.53) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4350559 0.83 ALDH1A1 (0.53) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4355069 0.81 MEN1 (0.51) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4350263 0.81 GRIN1 (0.72) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL4355067 0.81 MEN1 (0.51) MEN1KMT2ARAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MEN1 1725/4885KMT2A 3923/4885RAB9A 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.